It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2003.
2003 | Ahmedabad, Gujarat, India | ActiveArtemisia Lifesciences Private Limited, a active private limited company, was established on 21 March 2003 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24231GJ2003PTC042151. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Riasmo Lifesciences Private Limited. It upholds a compliant status. Its leadership includes Jyoti Jaiswal (Whole-Time Director), Raj Kumar Jaiswal (Managing Director). Past directors included Mahesh Prasad Ramdeo Gupta, Raj Kumar Jaiswal. It holds no open charges and ₹7.90 M settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 69 Green Parkambil Village Bopal Road, Ahmedabad, Gujarat, 380054.
U24231GJ2003PTC042151
042151
21 March 2003
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Artemisia Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jyoti Jaiswal | Whole-Time Director | 24 Aug 2013 | Current |
| Raj Kumar Jaiswal | Managing Director | 21 Mar 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Aug 2013 | Past |
| Pramod Abcsdd | Director | 24 Aug 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Artemisia Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 73.87% decrease in profit. The company's net worth observed a substantial decline by a decrease of 411.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Artemisia Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹7,900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2005 | Central Bank Of India | ₹6.80 M | Satisfied |
| 08 Dec 2004 | Central Bank Of India | ₹1.10 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Artemisia Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Artemisia Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Artemisia Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Artemisia Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Progress on Artemisia Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Ahmedabad. was documented.
A charge registered on 08 Dec 2004 via Charge ID 90102420 with Central Bank Of India was fully satisfied on 23 Oct 2018. was recorded as a recent event.
A charge registered on 05 Dec 2005 via Charge ID 80056200 with Central Bank Of India was fully satisfied on 06 Apr 2016. was recorded as a recent event.
Progress on Jyoti Jaiswal was appointed as a Whole-time director was appointed as a Whole-time director on 24 Aug 2013 & has been associated with this company since 12 years 3 months . was documented.
Progress on A charge with Central Bank Of India of Rs. 6.80 M registered on 05 Dec 2005 with Charge ID 80056200 was modified on 06 Nov 2009. was documented.
The CIN of Artemisia Lifesciences Private Limited is U24231GJ2003PTC042151.
Artemisia Lifesciences Private Limited is headquartered at 69 Green Parkambil Village Bopal Road, Ahmedabad, Gujarat, 380054.
Artemisia Lifesciences Private Limited was incorporated on 21 March 2003.
The current directors of Artemisia Lifesciences Private Limited are
The primary industry of Artemisia Lifesciences Private Limited is Pharma.
Artemisia Lifesciences Private Limited is unlisted.
The authorized capital of Artemisia Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Artemisia Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX